info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Closed System Drug Transfer Device Companies

Closed System Drug Transfer Devices (CSTDs) are specialized tools designed to minimize the risk of exposure to hazardous drugs during their handling, transfer, and administration. These devices are crucial in protecting healthcare workers and patients from the potential dangers associated with handling hazardous medications. Several companies are involved in the manufacturing and distribution of Closed System Drug Transfer Devices.


*Disclaimer: List of key companies in no particular orderLatest Closed System Drug Transfer Devices Companies Update


  • Oct 2023: The FDA has approved the EQUASHIELD® Syringe Unit for full-volume use, according to EQUASHIELD®, a top supplier of Closed System Transfer Devices (CSTDs) for dangerous medications. An incorporated barrier-type pressure equalization structure, a leak-prevention dry disconnection mechanism, and an enclosed closed-back syringe with a metal plunger rod are all part of the special CSTD Syringe Unit made by EQUASHIELD. These features help to reduce the risk of hazardous drug contamination by stopping vapor escape and plunger spoilage. This accomplishment marks a substantial advance for the sector, lifting the bar for security, effectiveness, and affordability. Since it has been the most widely used CSTD in the USA for five years, EQUASHIELD's extensive CSTD portfolio includes closed-back syringes and adaptors for various hazardous medication preparation and administration processes.




  • Feb 2023: The US Food & Drug Administration has granted its first product 510(k) certification to Zephyrus Innovations, a privately held medical device manufacturer and designer of safety syringes and Closed System Transfer Devices (CSTDs). This approval is for the Aeroject 3ml safety syringe. The first product in a line of safety syringes being created by Zephyrus is the Aeroject 3ml safety syringe. The need for safety syringes is rising in a market estimated to be worth $8.5 billion by 2024, with the US making up 40% of sales. Due to the potential for transferring bloodborne viruses and the growing prospect of class action lawsuits, poor safety outcomes can be both expensive and fatal. Demand for safer syringes has never been higher.


List of Closed System Drug Transfer Devices Key companies in the market

  • Equashield (US)

  • Simplivia Healthcare (Israel)

  • Corvida Medical (US)

  • Yukon Medical (US)

  • CODAN Medizinische Geräte (Germany)

  • VICTUS (US)

  • Caragen (US)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.